|Bid||46.00 x 3200|
|Ask||48.50 x 1000|
|Day's Range||47.27 - 48.08|
|52 Week Range||44.21 - 68.98|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||0.35 (0.71%)|
|1y Target Est||N/A|
Alan Valdes, director of floor operations at Silverbear Capital, joins Yahoo Finance's Alexis Christoforous from the floor of the New York Stock Exchange to discuss the latest market moves.
A rapidly changing healthcare environment in the United States, sluggish first quarter, declining margins and foreign exchange headwinds continue to hurt DENTSPLY SIRONA (XRAY).
The S&P 500’s top gainers on May 10 were: CenturyLink (CTL) gained 7.5%. Discovery Comm (DISCK) gained 6.9%. Discovery Comm A (DISCA) gained 6.9%. Envision Healthcare Holdings (EVHC) gained 5%. Dentsply Sirona (XRAY) gained 4.4%. CenturyLink
Stocks that moved substantially or traded heavily Monday: Athenahealth Inc., up $20.67 to $146.75 Elliott Management is offering about $6.5 billion to take the medical billing software maker private. Exxon ...
Strong performance in Europe and Rest of World boosts DENTAPLY's (XRAY) performance in Q1. However, a lowered guidance indicates looming concerns.
On May 3, Dentsply Sirona (XRAY) closed at $49.24 per share. The stock registered a fall of 2.7% on the day. The stock registered a 52-week low on April 2, when it traded at $48.25. However, it was trading at a 52-week high of $68.98 on November 28, 2017.
On a per-share basis, the York, Pennsylvania-based company said it had profit of 35 cents. Earnings, adjusted for non-recurring costs, came to 45 cents per share. The results exceeded Wall Street expectations. ...
Let’s talk about the popular DENTSPLY SIRONA Inc (NASDAQ:XRAY). The company’s shares received a lot of attention from a substantial price movement on the NasdaqGS over the last few months,Read More...
Dentsply Sirona (XRAY) will announce its 1Q18 results on May 7. The company has recently made some organizational changes and key management changes. It’s also recently announced its acquisition of OraMetrix to expand its orthodontic treatment solutions portfolio.
Dentsply Sirona (XRAY) accounts for ~0.29% of the total holdings of the Vanguard Mid-Cap ETF (VO). The company is set to release its 1Q18 results on May 7.
Dentsply Sirona (XRAY) is one of the leading dental technology providers in the United States. The company will announce its 1Q18 earnings results on May 7. It’s currently undergoing a restructuring program after failing to realize the expected synergies from its Dentsply International and Sirona Dental Systems merger in February 2016.
DENTSPLY's (XRAY) CAD/CAM unit is likely to drive the top line in Q1. Product innovations and strong R&D prospects are also likely to drive growth.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding XRAY totaled $14.30 billion.
On April 6, 2018, Dentsply Sirona (XRAY) ended at a closing price of $49.02 per share. The stock declined by ~0.14% on the day. XRAY stock was trading at a 52-week high of $68.98 on November 28, 2017. However, the company’s 52-week low came on April 2, 2018, at $48.25. This recent stock price decline was triggered by negative investor sentiments for the company due to recent target price cuts by Wall Street analysts following downward revisions and modelling adjustments in the company’s fiscal 4Q17 earnings release on March 2 and the recent OraMetrix acquisition announcement.
Dentsply Sirona (XRAY), one of the leading dental technology providers in the United States, recently outlined a turnaround plan to recover from the company’s disappointing performance in recent years. This weak performance was due to the lower-than-expected synergies delivered after the merger of Dentsply International and Sirona Dental Systems in February 2016, which led to the formation of Dentsply Sirona. For more detail, read Inside Dentsply Sirona’s New Turnaround Plan.
Henry Schein (HSIC) banks on part of its strategic plan, digital dentistry. In this regard, its latest joint venture with Internet Brands buoys optimism.
On March 26, 2018, Dentsply Sirona (XRAY) announced the acquisition of OraMetrix, a Texas-based privately held company. The acquisition aims to expand the orthodontic treatment solutions that Dentsply Sirona offers.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding XRAY totaled $3.79 billion.
In 2018, Dentsply Sirona (XRAY) is expected to register flat margins or a decline in EBIT (earnings before income and tax) margin. By comparison, peers Danaher (DHR), Zimmer Biomet Holdings (ZBH), and Integra Lifesciences (IART) registered operating margin growth of 16.5%, 10.3%, and 3.7%, respectively, in fiscal 2017. The company currently has an attractive margin profile and registered a gross margin of ~55% of the company’s total sales in 2017. As the company evaluated its impairment analysis results, it saw a significant impairment charge in 2017.
Dentsply Sirona (XRAY) reported its 2018 guidance during the company’s 4Q17 and fiscal 2017 earnings results release on March 2, 2018. For fiscal 2018, Dentsply Sirona has an adjusted EPS (earnings per share) guidance range of $2.70–$2.80, representing a growth rate of 8% to 11%. Dentsply Sirona expects to generate flat margins or a decline in its gross margin and operating margin due to currency headwinds, and the negative impact of the reductions in dealer equipment levels.